SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH LIRENTELIMAB, A MONOCLONAL ANTIBODY AGAINST SIGLEC-8, IN PATIENTS WITH EOSINOPHILIC GASTRITIS/DUODENITIS

Evan S. Dellon  ¹     Kathryn Peterson  ²     Joseph A. Murray  ³     Gary W. Falk  ⁴     Nirmala Gonsalves  ⁵     Robert Genta  ⁶     John Leung  ⁷     Paneez Khoury     Amy Klion     Sabine Hazan     Michael F. Vaezi     Adam Bledsoe     Sandy Durrani     Chao Wang     Camilla Shaw     Alan Chang     BHUPINDER SINGH     Amol Kamboj     Henrik Rasmussen     Marc E. Rothenberg     Ikuo Hirano     Mirn    
¹ University of North Carolina,Chapel Hill,United States
² University of Utah,Salt Lake City,United States
³ Mayo Clinic Rochester,Rochester,United States
⁴ University of Pennsylvania Perelman School of Medicine,Philadelphia,United States
⁵ Northwestern University,Chicago,United States
⁶ Baylor College of Medicine,Houston,United States
⁷ Tuf

Session
Eosinophilic oesophagitis: The essential

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)